130 related articles for article (PubMed ID: 36759059)
1. Characterization, antifungal susceptibility and virulence of Candida parapsilosis complex isolates in a tertiary hospital in Cantabria, Northern Spain.
Ruiz de Alegría Puig C; García Merino MDS; De Malet Pintos-Fonseca A; Agüero Balbín J
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Feb; 41(2):99-102. PubMed ID: 36759059
[TBL] [Abstract][Full Text] [Related]
2. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
[TBL] [Abstract][Full Text] [Related]
3. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of MALDI-TOF MS for Identification of Species in the Candida parapsilosis Complex from Candidiasis Cases.
Samantaray S; Singh R
J Appl Lab Med; 2022 Jun; 7(4):889-900. PubMed ID: 35348720
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the MALDI-TOF VITEK MS™ system for the identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis from bloodstream infections.
Nobrega de Almeida Júnior J; de Souza LB; Motta AL; Rossi F; Romano Di Gioia TS; Benard G; Del Negro GM
J Microbiol Methods; 2014 Oct; 105():105-8. PubMed ID: 25072839
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential.
Brilhante RSN; Sales JA; da Silva MLQ; de Oliveira JS; Pereira LA; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
J Med Microbiol; 2018 Jul; 67(7):903-914. PubMed ID: 29846153
[TBL] [Abstract][Full Text] [Related]
8. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
[TBL] [Abstract][Full Text] [Related]
9. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts,
Arastehfar A; Khodavaisy S; Daneshnia F; Najafzadeh MJ; Mahmoudi S; Charsizadeh A; Salehi MR; Zarrinfar H; Raeisabadi A; Dolatabadi S; Zare Shahrabadi Z; Zomorodian K; Pan W; Hagen F; Boekhout T
Front Cell Infect Microbiol; 2019; 9():264. PubMed ID: 31417877
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.
Maria S; Barnwal G; Kumar A; Mohan K; Vinod V; Varghese A; Biswas R
Rev Iberoam Micol; 2018; 35(3):147-150. PubMed ID: 29997030
[TBL] [Abstract][Full Text] [Related]
11. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
12. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification, virulence factors and antifungal susceptibility patterns of
Cakir N; Atalay MA; Koc AN; Kaan O; Sagiroglu P
Niger J Clin Pract; 2021 Jun; 24(6):853-859. PubMed ID: 34121733
[TBL] [Abstract][Full Text] [Related]
14. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
15. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
[TBL] [Abstract][Full Text] [Related]
16. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015.
Pharkjaksu S; Chongtrakool P; Suwannakarn K; Ngamskulrungroj P
Med Mycol; 2018 Jun; 56(4):426-433. PubMed ID: 28992058
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.
Silva AP; Miranda IM; Lisboa C; Pina-Vaz C; Rodrigues AG
J Clin Microbiol; 2009 Aug; 47(8):2392-7. PubMed ID: 19494078
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian
Arastehfar A; Daneshnia F; Najafzadeh MJ; Hagen F; Mahmoudi S; Salehi M; Zarrinfar H; Namvar Z; Zareshahrabadi Z; Khodavaisy S; Zomorodian K; Pan W; Theelen B; Kostrzewa M; Boekhout T; Lass-Flörl C
Front Cell Infect Microbiol; 2020; 10():206. PubMed ID: 32509592
[TBL] [Abstract][Full Text] [Related]
19.
Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
[No Abstract] [Full Text] [Related]
20. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
